2seventy bio, Inc. - Common Stock (NQ: TSVT )
4.750
+0.190
(+4.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about 2seventy bio, Inc. - Common Stock
![](https://g.foolcdn.com/editorial/images/750083/investing-screen-analysis-investor-growth-stocks-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for 2seventy bio
September 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for 2seventy bio's Future
August 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where 2seventy bio Stands With Analysts
July 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1210.jpeg?width=1200&height=800&fit=crop)
2seventy bio: Q1 Earnings Insights
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
2seventy bio's Return On Capital Employed Overview
March 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/15/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/13/tsvt.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/17/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/15/paysafe_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/15/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/aclx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/17/seattle_childrens_hospital.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/14/tsvt.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/04/stock-biotech-16-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-Drugs-09-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_7727.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.